Obesity and cognitive decline: Role of inflammation and vascular changes

Frontiers in Neuroscience

Volumn 8, Issue OCT, 2014, Pages

  Nguyen, J C D ^a   Killcross, A S ^b   Jenkins, T A ^a  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Alzheimer's disease; Cytokines; Dementia; Hippocampus; Memory; Neuroinflammation

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL MODEL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN ATROPHY; CEREBROVASCULAR DISEASE; DEMENTIA; HUMAN; MENTAL DETERIORATION; MENTAL DISEASE; MICROGLIA; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OBESITY; VASCULAR LESION; WEIGHT GAIN;

EID: 84949117755     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00375     Document Type: Article

References (139)

1. Alzoubi, K.H., Khabour, O.F., Salah, H.A., and Hasan, Z. (2013). Vitamin E prevents highfat high-carbohydrates diet-induced memory impairment: the role of oxidative stress. Physiol Behav 119, 72-78. doi: 10.1016/j.physbeh.2013.06.011.
2. Amieva, H., Jacqmin-Gadda, H., Orgogozo, J.M., Le Carret, N., Helmer, C., Letenneur, L., Barberger-Gateau, P., Fabrigoule, C., and Dartigues, J.F. (2005). The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 128, 1093-1101. doi: Doi 10.1093/Brain/Awh451.
3. Andre, C., Dinel, A.L., Ferreira, G., Laye, S., and Castanon, N. (2014). Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: Focus on brain indoleamine 2,3-dioxygenase activation. Brain Behav Immun. doi: 10.1016/j.bbi.2014.03.012.
4. Anstey, K.J., Cherbuin, N., Budge, M., and Young, J. (2011). Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev 12, e426-437. doi: 10.1111/j.1467-789X.2010.00825.x.
5. Ballabh, P., Braun, A., and Nedergaard, M. (2004). The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16, 1-13. doi: 10.1016/j.nbd.2003.12.016.
6. Banks, W.A., Burney, B.O., and Robinson, S.M. (2008). Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier. Peptides 29, 2061-2065. doi: DOI 10.1016/j.peptides.2008.07.001.
7. Banks, W.A., Coon, A.B., Robinson, S.M., Moinuddin, A., Shultz, J.M., Nakaoke, R., and Morley, J.E. (2004). Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 53, 1253-1260. doi: DOI 10.2337/diabetes.53.5.1253.
8. Beach, T.G., Walker, R., and Mcgeer, E.G. (1989). Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 2, 420-436. doi: 10.1002/glia.440020605.
9. Besser, L.M., Gill, D.P., Monsell, S.E., Brenowitz, W., Meranus, D.H., Kukull, W., and Gustafson, D.R. (2014). Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord 28, 36-43. doi: 10.1097/wad.0000000000000005.
10. Birks, J. (2006). Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev, CD005593. doi: 10.1002/14651858.CD005593.
11. Blennow, K., Wallin, A., Fredman, P., Karlsson, I., Gottfries, C.G., and Svennerholm, L. (1990). Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol Scand 81, 323-326.
12. Bliss, T.V., and Collingridge, G.L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39. doi: 10.1038/361031a0.
13. Boitard, C., Cavaroc, A., Sauvant, J., Aubert, A., Castanon, N., Laye, S., and Ferreira, G. (2014). Impairment of hippocampal-dependent memory induced by juvenile high-fat diet intake is associated with enhanced hippocampal inflammation in rats. Brain Behavior and Immunity 40, 9-17. doi: DOI 10.1016/j.bbi.2014.03.005.
14. Buchman, A.S., Wilson, R.S., Bienias, J.L., Shah, R.C., Evans, D.A., and Bennett, D.A. (2005). Change in body mass index and risk of incident Alzheimer disease. Neurology 65, 892-897. doi: 10.1212/01.wnl.0000176061.33817.90.
15. Calvo-Ochoa, E., Hernandez-Ortega, K., Ferrera, P., Morimoto, S., and Arias, C. (2014). Short-term high-fat-and-fructose feeding produces insulin signaling alterations accompanied by neurite and synaptic reduction and astroglial activation in the rat hippocampus. J Cereb Blood Flow Metab 34, 1001-1008. doi: 10.1038/jcbfm.2014.48.
16. Cano, V., Valladolid-Acebes, I., Hernandez-Nuno, F., Merino, B., Del Olmo, N., Chowen, J.A., and Ruiz-Gayo, M. (2014). Morphological changes in glial fibrillary acidic protein immunopositive astrocytes in the hippocampus of dietary-induced obese mice. Neuroreport 25, 819-822. doi: Doi 10.1097/Wnr.0000000000000180.
17. Castanon, N., Lasselin, J., and Capuron, L. (2014). Neuropsychiatric comorbidity in obesity: role of inflammatory processes. Front Endocrinol (Lausanne) 5, 74. doi: 10.3389/fendo.2014.00074.
18. Cournot, M., Marquie, J.C., Ansiau, D., Martinaud, C., Fonds, H., Ferrieres, J., and Ruidavets, J.B. (2006). Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 67, 1208-1214. doi: 10.1212/01.wnl.0000238082.13860.50.
19. Craig, D., and Birks, J. (2005). Rivastigmine for vascular cognitive impairment. Cochrane Database Syst Rev, CD004744. doi: 10.1002/14651858.CD004744.pub2.
20. Dantzer, R., O'connor, J.C., Freund, G.G., Johnson, R.W., and Kelley, K.W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9, 46-56. doi: 10.1038/nrn2297.
21. Davidson, T.L., Monnot, A., Neal, A.U., Martin, A.A., Horton, J.J., and Zheng, W. (2012). The effects of a high-energy diet on hippocampal-dependent discrimination performance and blood-brain barrier integrity differ for diet-induced obese and dietresistant rats. Physiol Behav 107, 26-33. doi: 10.1016/j.physbeh.2012.05.015.
22. De Hert, M., Dekker, J.M., Wood, D., Kahl, K.G., Holt, R.I., and Moller, H.J. (2009). Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 24, 412-424. doi: 10.1016/j.eurpsy.2009.01.005.
23. De Wit, L.M., Fokkema, M., Van Straten, A., Lamers, F., Cuijpers, P., and Penninx, B.W. (2010). Depressive and anxiety disorders and the association with obesity, physical, and social activities. Depress Anxiety 27, 1057-1065. doi: 10.1002/da.20738.
24. Debette, S., Seshadri, S., Beiser, A., Au, R., Himali, J.J., Palumbo, C., Wolf, P.A., and Decarli, C. (2011). Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77, 461-468. doi: Doi 10.1212/Wnl.0b013e318227b227.
25. Den Heijer, T., Van Der Lijn, F., Koudstaal, P.J., Hofman, A., Van Der Lugt, A., Krestin, G.P., Niessen, W.J., and Breteler, M.M. (2010). A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain 133, 1163-1172. doi: 10.1093/brain/awq048.
26. Diano, S., Farr, S.A., Benoit, S.C., Mcnay, E.C., Da Silva, I., Horvath, B., Gaskin, F.S., Nonaka, N., Jaeger, L.B., Banks, W.A., Morley, J.E., Pinto, S., Sherwin, R.S., Xu, L., Yamada, K.A., Sleeman, M.W., Tschop, M.H., and Horvath, T.L. (2006). Ghrelin controls hippocampal spine synapse density and memory performance. Nature Neuroscience 9, 381-388. doi: Doi 10.1038/Nn1656.
27. Dinel, A.L., Andre, C., Aubert, A., Ferreira, G., Laye, S., and Castanon, N. (2011). Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome. PLoS One 6, e24325. doi: 10.1371/journal.pone.0024325.
28. Drake, C., Boutin, H., Jones, M.S., Denes, A., Mccoll, B.W., Selvarajah, J.R., Hulme, S., Georgiou, R.F., Hinz, R., Gerhard, A., Vail, A., Prenant, C., Julyan, P., Maroy, R., Brown, G., Smigova, A., Herholz, K., Kassiou, M., Crossman, D., Francis, S., Proctor, S.D., Russell, J.C., Hopkins, S.J., Tyrrell, P.J., Rothwell, N.J., and Allan, S.M. (2011). Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun 25, 1113-1122. doi: 10.1016/j.bbi.2011.02.008.
29. Elias, M.F., Beiser, A., Wolf, P.A., Au, R., White, R.F., and D'agostino, R.B. (2000). The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol 57, 808-813.
30. Elias, M.F., Elias, P.K., Sullivan, L.M., Wolf, P.A., and D'agostino, R.B. (2003). Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord 27, 260-268.
31. Elias, M.F., Elias, P.K., Sullivan, L.M., Wolf, P.A., and D'agostino, R.B. (2005). Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol Aging 26 Suppl 1, 11-16.
32. Enache, D., Winblad, B., and Aarsland, D. (2011). Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 24, 461-472. doi: 10.1097/YCO.0b013e32834bb9d4.
33. Erion, J.R., Wosiski-Kuhn, M., Dey, A., Hao, S., Davis, C.L., Pollock, N.K., and Stranahan, A.M. (2014). Obesity elicits interleukin 1-mediated deficits in hippocampal synaptic plasticity. J Neurosci 34, 2618-2631. doi: 10.1523/JNEUROSCI.4200-13.2014.
34. Farr, S.A., Yamada, K.A., Butterfield, D.A., Abdul, H.M., Xu, L., Miller, N.E., Banks, W.A., and Morley, J.E. (2008). Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 149, 2628-2636. doi: 10.1210/en.2007-1722.
35. Fitzpatrick, A.L., Kuller, L.H., Lopez, O.L., Diehr, P., O'meara, E.S., Longstreth, W.T., Jr., and Luchsinger, J.A. (2009). Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 66, 336-342. doi: 10.1001/archneurol.2008.582.
36. Freeman, L.R., and Granholm, A.C. (2012). Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet. J Cereb Blood Flow Metab 32, 643-653. doi: 10.1038/jcbfm.2011.168jcbfm2011168 [pii].
37. Garcia-Caceres, C., Yi, C.X., and Tschop, M.H. (2013). Hypothalamic Astrocytes in Obesity. Endocrinology and Metabolism Clinics of North America 42, 57-+. doi: DOI 10.1016/j.ecl.2012.11.003.
38. Geiger, B.M., Behr, G.G., Frank, L.E., Caldera-Siu, A.D., Beinfeld, M.C., Kokkotou, E.G., and Pothos, E.N. (2008). Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. FASEB J 22, 2740-2746. doi: 10.1096/fj.08-110759.
39. Gemma, C., and Bickford, P.C. (2007). Interleukin-1beta and caspase-1: players in the regulation of age-related cognitive dysfunction. Rev Neurosci 18, 137-148.
40. Glisky, E.L. (2007). "Changes in Cognitive Function in Human Aging," in Brain Aging: Models, Methods, and Mechanisms, ed. D.R. Riddle. (Boca Raton (FL)).
41. Gorelick, P.B., Scuteri, A., Black, S.E., Decarli, C., Greenberg, S.M., Iadecola, C., Launer, L.J., Laurent, S., Lopez, O.L., Nyenhuis, D., Petersen, R.C., Schneider, J.A., Tzourio, C., Arnett, D.K., Bennett, D.A., Chui, H.C., Higashida, R.T., Lindquist, R., Nilsson, P.M., Roman, G.C., Sellke, F.W., and Seshadri, S. (2011). Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 42, 2672-2713. doi: STR.0b013e3182299496 [pii]10.1161/STR.0b013e3182299496.
42. Granholm, A.C., Bimonte-Nelson, H.A., Moore, A.B., Nelson, M.E., Freeman, L.R., and Sambamurti, K. (2008). Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J Alzheimers Dis 14, 133-145.
43. Grundy, S.M. (2004). Obesity, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology & Metabolism 89, 2595-2600. doi: Doi 10.1210/Jc.2004- 0372.
44. Gunstad, J., Paul, R.H., Cohen, R.A., Tate, D.F., Spitznagel, M.B., and Gordon, E. (2007). Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Comprehensive Psychiatry 48, 57-61. doi: DOI 10.1016/j.comppsych.2006.05.001.
45. Gustafson, D., Lissner, L., Bengtsson, C., Bjorkelund, C., and Skoog, I. (2004). A 24-year follow-up of body mass index and cerebral atrophy. Neurology 63, 1876-1881.
46. Gustafson, D., Rothenberg, E., Blennow, K., Steen, B., and Skoog, I. (2003). An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163, 1524- 1528. doi: 10.1001/archinte.163.13.1524.
47. Gustafson, D.R., Backman, K., Joas, E., Waern, M., Ostling, S., Guo, X., and Skoog, I. (2012). 37 years of body mass index and dementia: observations from the prospective population study of women in Gothenburg, Sweden. J Alzheimers Dis 28, 163-171. doi: 10.3233/jad-2011-110917.
48. Gustafson, D.R., Backman, K., Waern, M., Ostling, S., Guo, X., Zandi, P., Mielke, M.M., Bengtsson, C., and Skoog, I. (2009). Adiposity indicators and dementia over 32 years in Sweden. Neurology 73, 1559-1566. doi: 10.1212/WNL.0b013e3181c0d4b6.
49. Gustafson, D.R., Karlsson, C., Skoog, I., Rosengren, L., Lissner, L., and Blennow, K. (2007). Mid-life adiposity factors relate to blood-brain barrier integrity in late life. J Intern Med 262, 643-650. doi: 10.1111/j.1365-2796.2007.01869.x.
50. Hansen, H.H., Jensen, M.M., Overgaard, A., Weikop, P., and Mikkelsen, J.D. (2013). Tesofensine induces appetite suppression and weight loss with reversal of low forebrain dopamine levels in the diet-induced obese rat. Pharmacol Biochem Behav 110, 265-271. doi: 10.1016/j.pbb.2013.07.018.
51. Harrison, N.A., Doeller, C.F., Voon, V., Burgess, N., and Critchley, H.D. (2014). Peripheral Inflammation Acutely Impairs Human Spatial Memory via Actions on Medial Temporal Lobe Glucose Metabolism. Biol Psychiatry 76, 585-593. doi: 10.1016/j.biopsych.2014.01.005.
52. Haslam, D.W., and James, W.P.T. (2005). Obesity. Lancet 366, 1197-1209. doi: Doi 10.1016/S0140-6736(05)67483-1.
53. Hasnain, M., Vieweg, W.V., and Hollett, B. (2012). Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians. Postgrad Med 124, 154-167. doi: 10.3810/pgm.2012.07.2577.
54. Hassing, L.B., Dahl, A.K., Pedersen, N.L., and Johansson, B. (2010). Overweight in midlife is related to lower cognitive function 30 years later: a prospective study with longitudinal assessments. Dement Geriatr Cogn Disord 29, 543-552. doi: 10.1159/000314874.
55. Hermsdorff, H.H., Zulet, M.A., Puchau, B., and Martinez, J.A. (2011). Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 34, 161-170. doi: 10.1007/s10753- 010-9219-y.
56. Hoare, E., Skouteris, H., Fuller-Tyszkiewicz, M., Millar, L., and Allender, S. (2014). Associations between obesogenic risk factors and depression among adolescents: a systematic review. Obesity Reviews 15, 40-51. doi: Doi 10.1111/Obr.12069.
57. Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
58. Hryhorczuk, C., Sharma, S., and Fulton, S.E. (2013). Metabolic disturbances connecting obesity and depression. Front Neurosci 7, 177. doi: 10.3389/fnins.2013.00177.
59. Hummel, K.P., Dickie, M.M., and Coleman, D.L. (1966). Diabetes, a new mutation in the mouse. Science 153, 1127-1128.
60. Itagaki, S., Mcgeer, P.L., Akiyama, H., Zhu, S., and Selkoe, D. (1989). Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 24, 173-182.
61. Jack, C.R., Jr., Petersen, R.C., Xu, Y., O'brien, P.C., Smith, G.E., Ivnik, R.J., Boeve, B.F., Tangalos, E.G., and Kokmen, E. (2000). Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55, 484-489.
62. Jahangiri, A., Wilson, P.G., Hou, T.F., Brown, A., King, V.L., and Tannock, L.R. (2013). Serum Amyloid A is Found on ApoB-Containing Lipoproteins in Obese Humans with Diabetes. Obesity 21, 993-996. doi: Doi 10.1002/Oby.20126.
63. Jankowsky, J.L., and Patterson, P.H. (1999). Cytokine and growth factor involvement in long-term potentiation. Mol Cell Neurosci 14, 273-286.
64. Jaremka, L.M., Lindgren, M.E., and Kiecolt-Glaser, J.K. (2013). Synergistic Relationships among Stress, Depression, and Troubled Relationships: Insights from Psychoneuroimmunology. Depression and Anxiety 30, 288-296. doi: Doi 10.1002/Da.22078.
65. Jeon, B.T., Jeong, E.A., Shin, H.J., Lee, Y., Lee, D.H., Kim, H.J., Kang, S.S., Cho, G.J., Choi, W.S., and Roh, G.S. (2012). Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a highfat diet. Diabetes 61, 1444-1454. doi: 10.2337/db11-1498.
66. Jeong, S.K., Nam, H.S., Son, M.H., Son, E.J., and Cho, K.H. (2005). Interactive effect of obesity indexes on cognition. Dement Geriatr Cogn Disord 19, 91-96.
67. Julien, C., Tremblay, C., Phivilay, A., Berthiaume, L., Emond, V., Julien, P., and Calon, F. (2010). High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol Aging 31, 1516-1531. doi: 10.1016/j.neurobiolaging.2008.08.022.
68. Jurdak, N., Lichtenstein, A.H., and Kanarek, R.B. (2008). Diet-induced obesity and spatial cognition in young male rats. Nutr Neurosci 11, 48-54.
69. Kanoski, S.E., and Davidson, T.L. (2010). Different patterns of memory impairments accompany short- and longer-term maintenance on a high-energy diet. J Exp Psychol Anim Behav Process 36, 313-319.
70. Kanoski, S.E., Zhang, Y., Zheng, W., and Davidson, T.L. (2010). The effects of a highenergy diet on hippocampal function and blood-brain barrier integrity in the rat. J Alzheimers Dis 21, 207-219. doi: 10.3233/JAD-2010-091414.
71. Karimi, S.A., Salehi, I., Komaki, A., Sarihi, A., Zarei, M., and Shahidi, S. (2013). Effect of high-fat diet and antioxidants on hippocampal long-term potentiation in rats: an in vivo study. Brain Res 1539, 1-6. doi: 10.1016/j.brainres.2013.09.029.
72. Kim, I.Y., Hwang, I.K., Choi, J.W., Yoo, K.Y., Kim, Y.N., Yi, S.S., Won, M.H., Lee, I.S., Yoon, Y.S., and Seong, J.K. (2009). Effects of high cholesterol diet on newly generated cells in the dentate gyrus of C57BL/6N and C3H/HeN mice. J Vet Med Sci 71, 753-758.
73. Koga, S., Kojima, A., Kuwabara, S., and Yoshiyama, Y. (2014). Immunohistochemical analysis of tau phosphorylation and astroglial activation with enhanced leptin receptor expression in diet-induced obesity mouse hippocampus. Neurosci Lett 571, 11-16. doi: 10.1016/j.neulet.2014.04.028.
74. Kosari, S., Badoer, E., Nguyen, J.C., Killcross, A.S., and Jenkins, T.A. (2012). Effect of western and high fat diets on memory and cholinergic measures in the rat. Behav Brain Res 235, 98-103. doi: 10.1016/j.bbr.2012.07.017.
75. Koyama, A., O'brien, J., Weuve, J., Blacker, D., Metti, A.L., and Yaffe, K. (2013). The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a metaanalysis. J Gerontol A Biol Sci Med Sci 68, 433-440. doi: 10.1093/gerona/gls187.
76. Lee, Y.H., Martin, J.M., Maple, R.L., Tharp, W.G., and Pratley, R.E. (2009). Plasma Amyloid-beta Peptide Levels Correlate with Adipocyte Amyloid Precursor Protein Gene Expression in Obese Individuals. Neuroendocrinology 90, 383-390. doi: Doi 10.1159/000235555.
77. Li, W., Prakash, R., Chawla, D., Du, W., Didion, S.P., Filosa, J.A., Zhang, Q., Brann, D.W., Lima, V.V., Tostes, R.C., and Ergul, A. (2013). Early effects of high-fat diet on neurovascular function and focal ischemic brain injury. Am J Physiol Regul Integr Comp Physiol 304, R1001-1008. doi: 10.1152/ajpregu.00523.2012.
78. Liang, J., Matheson, B.E., Kaye, W.H., and Boutelle, K.N. (2014). Neurocognitive correlates of obesity and obesity-related behaviors in children and adolescents. Int J Obes (Lond) 38, 494-506. doi: 10.1038/ijo.2013.142.
79. Lindqvist, A., Mohapel, P., Bouter, B., Frielingsdorf, H., Pizzo, D., Brundin, P., and Erlanson-Albertsson, C. (2006). High-fat diet impairs hippocampal neurogenesis in male rats. Eur J Neurol 13, 1385-1388. doi: 10.1111/j.1468-1331.2006.01500.x.
80. Loane, D.J., and Byrnes, K.R. (2010). Role of Microglia in Neurotrauma. Neurotherapeutics 7, 366-377.
81. Lokken, K.L., Boeka, A.G., Austin, H.M., Gunstad, J., and Harmon, C.M. (2009). Evidence of executive dysfunction in extremely obese adolescents: a pilot study. Surg Obes Relat Dis 5, 547-552. doi: 10.1016/j.soard.2009.05.008.
82. Loprinzi, P.D., Herod, S.M., Cardinal, B.J., and Noakes, T.D. (2013). Physical activity and the brain: A review of this dynamic, bi-directional relationship. Brain Research 1539, 95-104. doi: DOI 10.1016/j.brainres.2013.10.004.
83. Luchsinger, J.A., Patel, B., Tang, M.X., Schupf, N., and Mayeux, R. (2007). Measures of adiposity and dementia risk in elderly persons. Arch Neurol 64, 392-398. doi: 10.1001/archneur.64.3.392.
84. Lucke, J., and Partridge, B. (2013). Towards a Smart Population: A Public Health Framework for Cognitive Enhancement. Neuroethics 6, 419-427. doi: DOI 10.1007/s12152-012- 9167-3.
85. Luppino, F.S., De Wit, L.M., Bouvy, P.F., Stijnen, T., Cuijpers, P., Penninx, B.W., and Zitman, F.G. (2010). Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 67, 220-229. doi: 10.1001/archgenpsychiatry.2010.2.
86. Lyketsos, C.G., Lopez, O., Jones, B., Fitzpatrick, A.L., Breitner, J., and Dekosky, S. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288, 1475-1483.
87. Lynch, C.M., Kinzenbaw, D.A., Chen, X., Zhan, S., Mezzetti, E., Filosa, J., Ergul, A., Faulkner, J.L., Faraci, F.M., and Didion, S.P. (2013). Nox2-derived superoxide contributes to cerebral vascular dysfunction in diet-induced obesity. Stroke 44, 3195- 3201. doi: 10.1161/STROKEAHA.113.001366.
88. Mcneilly, A.D., Williamson, R., Sutherland, C., Balfour, D.J., and Stewart, C.A. (2011). High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task. Behav Brain Res 217, 134-141.
89. Megna, J.L., Schwartz, T.L., Siddiqui, U.A., and Herrera Rojas, M. (2011). Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions. Ann Clin Psychiatry 23, 131-140.
90. Miller, A.A., and Spencer, S.J. (2014). Obesity and neuroinflammation: A pathway to cognitive impairment. Brain Behav Immun. doi: 10.1016/j.bbi.2014.04.001.
91. Molteni, R., Barnard, R.J., Ying, Z., Roberts, C.K., and Gomez-Pinilla, F. (2002). A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 112, 803-814.
92. Mond, J.M., Rodgers, B., Hay, P.J., Darby, A., Owen, C., Baune, B.T., and Kennedy, R.L. (2007). Obesity and impairment in psychosocial functioning in women: the mediating role of eating disorder features. Obesity (Silver Spring) 15, 2769-2779. doi: 10.1038/oby.2007.329.
93. Moraes, J.C., Coope, A., Morari, J., Cintra, D.E., Roman, E.A., Pauli, J.R., Romanatto, T., Carvalheira, J.B., Oliveira, A.L., Saad, M.J., and Velloso, L.A. (2009). High-fat diet induces apoptosis of hypothalamic neurons. PLoS One 4, e5045. doi: 10.1371/journal.pone.0005045.
94. Morganstern, I., Ye, Z., Liang, S., Fagan, S., and Leibowitz, S.F. (2012). Involvement of cholinergic mechanisms in the behavioral effects of dietary fat consumption. Brain Res 1470, 24-34. doi: 10.1016/j.brainres.2012.06.004.
95. Mrak, R.E. (2009). Alzheimer-type neuropathological changes in morbidly obese elderly individuals. Clinical Neuropathology 28, 40-45.
96. Murray, A.J., Knight, N.S., Cochlin, L.E., Mcaleese, S., Deacon, R.M., Rawlins, J.N., and Clarke, K. (2009). Deterioration of physical performance and cognitive function in rats with short-term high-fat feeding. Faseb J 23, 4353-4360.
97. National Institute on Aging, A.R.I.W.G. (1997). Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18, S1-2.
98. Odegaard, J.I., and Chawla, A. (2013). Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 339, 172-177. doi: 10.1126/science.1230721.
99. Ouchi, N., Parker, J.L., Lugus, J.J., and Walsh, K. (2011). Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11, 85-97. doi: 10.1038/nri2921.
100. Pan, A., Keum, N., Okereke, O.I., Sun, Q., Kivimaki, M., Rubin, R.R., and Hu, F.B. (2012). Bidirectional Association Between Depression and Metabolic Syndrome A systematic review and meta-analysis of epidemiological studies. Diabetes Care 35, 1171-1180. doi: Doi 10.2337/Dc11-2055.
101. Pannacciulli, N., Del Parigi, A., Chen, K., Le, D.S., Reiman, E.M., and Tataranni, P.A. (2006). Brain abnormalities in human obesity: a voxel-based morphometric study. Neuroimage 31, 1419-1425. doi: 10.1016/j.neuroimage.2006.01.047.
102. Panza, F., Frisardi, V., Capurso, C., Imbimbo, B.P., Vendemiale, G., Santamato, A., D'onofrio, G., Seripa, D., Sancarlo, D., Pilotto, A., and Solfrizzi, V. (2010). Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis 21, 691-724. doi: 10.3233/jad-2010-091669.
103. Pohl, J., Woodside, B., and Luheshi, G.N. (2009). Changes in hypothalamically mediated acute-phase inflammatory responses to lipopolysaccharide in diet-induced obese rats. Endocrinology 150, 4901-4910. doi: 10.1210/en.2009-0526.
104. Puig, K.L., Floden, A.M., Adhikari, R., Golovko, M.Y., and Combs, C.K. (2012). Amyloid Precursor Protein and Proinflammatory Changes Are Regulated in Brain and Adipose Tissue in a Murine Model of High Fat Diet-Induced Obesity. Plos One 7. doi: ARTN e30378 DOI 10.1371/journal.pone.0030378.
105. Raji, C.A., Lopez, O.L., Kuller, L.H., Carmichael, O.T., and Becker, J.T. (2009). Age, Alzheimer disease, and brain structure. Neurology 73, 1899-1905. doi: 10.1212/WNL.0b013e3181c3f293.
106. Refolo, L.M., Malester, B., Lafrancois, J., Bryant-Thomas, T., Wang, R., Tint, G.S., Sambamurti, K., Duff, K., and Pappolla, M.A. (2000). Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7, 321-331. doi: 10.1006/nbdi.2000.0304.
107. Reynolds, G.P., and Kirk, S.L. (2010). Metabolic side effects of antipsychotic drug treatment- -pharmacological mechanisms. Pharmacol Ther 125, 169-179. doi: 10.1016/j.pharmthera.2009.10.010.
108. Rivera, P., Perez-Martin, M., Pavon, F.J., Serrano, A., Crespillo, A., Cifuentes, M., Lopez- Avalos, M.D., Grondona, J.M., Vida, M., Fernandez-Llebrez, P., De Fonseca, F.R., and Suarez, J. (2013). Pharmacological administration of the isoflavone daidzein enhances cell proliferation and reduces high fat diet-induced apoptosis and gliosis in the rat hippocampus. PLoS One 8, e64750. doi: 10.1371/journal.pone.0064750.
109. Sabia, S., Nabi, H., Kivimaki, M., Shipley, M.J., Marmot, M.G., and Singh-Manoux, A. (2009). Health behaviors from early to late midlife as predictors of cognitive function: The Whitehall II study. Am J Epidemiol 170, 428-437. doi: 10.1093/aje/kwp161.
110. Serrano-Pozo, A., Frosch, M.P., Masliah, E., and Hyman, B.T. (2011). Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1, a006189. doi: 10.1101/cshperspect.a006189.
111. Serretti, A., and Mandelli, L. (2010). Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 71, 1259-1272. doi: 10.4088/JCP.09r05346blu.
112. Shanley, L.J., Irving, A.J., and Harvey, J. (2001). Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. Journal of Neuroscience 21, art. no.- RC186.
113. Skoog, I., Wallin, A., Fredman, P., Hesse, C., Aevarsson, O., Karlsson, I., Gottfries, C.G., and Blennow, K. (1998). A population study on blood-brain barrier function in 85- year-olds: relation to Alzheimer's disease and vascular dementia. Neurology 50, 966- 971.
114. Sofroniew, M.V., and Vinters, H.V. (2010). Astrocytes: biology and pathology. Acta Neuropathologica 119, 7-35. doi: DOI 10.1007/s00401-009-0619-8.
115. Solfrizzi, V., Panza, F., Colacicco, A.M., D'introno, A., Capurso, C., Torres, F., Grigoletto, F., Maggi, S., Del Parigi, A., Reiman, E.M., Caselli, R.J., Scafato, E., Farchi, G., and Capurso, A. (2004). Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 63, 1882-1891.
116. Souza, C.G., Moreira, J.D., Siqueira, I.R., Pereira, A.G., Rieger, D.K., Souza, D.O., Souza, T.M., Portela, L.V., and Perry, M.L. (2007). Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sci 81, 198-203. doi: 10.1016/j.lfs.2007.05.001.
117. Stewart, R., Masaki, K., Xue, Q.L., Peila, R., Petrovitch, H., White, L.R., and Launer, L.J. (2005). A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 62, 55-60. doi: 10.1001/archneur.62.1.55.
118. Stranahan, A.M., Norman, E.D., Lee, K., Cutler, R.G., Telljohann, R.S., Egan, J.M., and Mattson, M.P. (2008). Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 18, 1085-1088. doi: 10.1002/hipo.20470.
119. Su, G.C., Arendash, G.W., Kalaria, R.N., Bjugstad, K.B., and Mullan, M. (1999). Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage. Brain Res 818, 105-117.
120. Sumarac-Dumanovic, M., Stevanovic, D., Ljubic, A., Jorga, J., Simic, M., Stamenkovic- Pejkovic, D., Starcevic, V., Trajkovic, V., and Micic, D. (2009). Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) 33, 151-156. doi: 10.1038/ijo.2008.216.
121. Taki, Y., Kinomura, S., Sato, K., Inoue, K., Goto, R., Okada, K., Uchida, S., Kawashima, R., and Fukuda, H. (2008). Relationship between body mass index and gray matter volume in 1,428 healthy individuals. Obesity 16, 119-124. doi: Doi 10.1038/Oby.2007.4.
122. Thewissen, M.M., Damoiseaux, J.G., Duijvestijn, A.M., Van Greevenbroek, M.M., Van Der Kallen, C.J., Feskens, E.J., Blaak, E.E., Schalkwijk, C.G., Stehouwer, C.D., Cohen Tervaert, J.W., and Ferreira, I. (2011). Abdominal fat mass is associated with adaptive immune activation: the CODAM Study. Obesity (Silver Spring) 19, 1690-1698. doi: 10.1038/oby.2010.337.
123. Thirumangalakudi, L., Prakasam, A., Zhang, R., Bimonte-Nelson, H., Sambamurti, K., Kindy, M.S., and Bhat, N.R. (2008). High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem 106, 475-485. doi: JNC5415 [pii]10.1111/j.1471-4159.2008.05415.x.
124. Tomassoni, D., Nwankwo, I.E., Gabrielli, M.G., Bhatt, S., Muhammad, A.B., Lokhandwala, M.F., Tayebati, S.K., and Amenta, F. (2013). Astrogliosis in the brain of obese Zucker rat: A model of metabolic syndrome. Neuroscience Letters 543, 136-141. doi: DOI 10.1016/j.neulet.2013.03.025.
125. Trollor, J.N., Smith, E., Agars, E., Kuan, S.A., Baune, B.T., Campbell, L., Samaras, K., Crawford, J., Lux, O., Kochan, N.A., Brodaty, H., and Sachdev, P. (2012). The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study. Age (Dordr) 34, 1295-1308. doi: 10.1007/s11357-011-9301-x.
126. Tucsek, Z., Toth, P., Sosnowska, D., Gautam, T., Mitschelen, M., Koller, A., Szalai, G., Sonntag, W.E., Ungvari, Z., and Csiszar, A. (2014a). Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in Beta-amyloid generation and Alzheimer's disease. J Gerontol A Biol Sci Med Sci 69, 1212-1226. doi: 10.1093/gerona/glt177.
127. Tucsek, Z., Toth, P., Tarantini, S., Sosnowska, D., Gautam, T., Warrington, J.P., Giles, C.B., Wren, J.D., Koller, A., Ballabh, P., Sonntag, W.E., Ungvari, Z., and Csiszar, A. (2014b). Aging Exacerbates Obesity-induced Cerebromicrovascular Rarefaction, Neurovascular Uncoupling, and Cognitive Decline in Mice. J Gerontol A Biol Sci Med Sci. doi: 10.1093/gerona/glu080.
128. Valente, T., Hidalgo, J., Bolea, I., Ramirez, B., Angles, N., Reguant, J., Morello, J.R., Gutierrez, C., Boada, M., and Unzeta, M. (2009). A diet enriched in polyphenols and polyunsaturated fatty acids, LMN diet, induces neurogenesis in the subventricular zone and hippocampus of adult mouse brain. J Alzheimers Dis 18, 849-865. doi: 10.3233/JAD-2009-1188.
129. Visser, M., Bouter, L.M., Mcquillan, G.M., Wener, M.H., and Harris, T.B. (1999). Elevated C-reactive protein levels in overweight and obese adults. Jama 282, 2131-2135.
130. Wardle, J., and Cooke, L. (2005). The impact of obesity on psychological well-being. Best Pract Res Clin Endocrinol Metab 19, 421-440. doi: 10.1016/j.beem.2005.04.006.
131. Weisberg, S.P., Mccann, D., Desai, M., Rosenbaum, M., Leibel, R.L., and Ferrante, A.W., Jr. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808. doi: 10.1172/jci19246.
132. Whitmer, R.A., Gunderson, E.P., Barrett-Connor, E., Quesenberry, C.P., Jr., and Yaffe, K. (2005). Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. Bmj 330, 1360.
133. Winer, S., Paltser, G., Chan, Y., Tsui, H., Engleman, E., Winer, D., and Dosch, H.M. (2009). Obesity predisposes to Th17 bias. Eur J Immunol 39, 2629-2635. doi: 10.1002/eji.200838893.
134. Wu, A., Molteni, R., Ying, Z., and Gomez-Pinilla, F. (2003). A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor. Neuroscience 119, 365-375.
135. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., and Chen, H. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821- 1830. doi: 10.1172/jci19451.
136. Yau, P.L., Castro, M.G., Tagani, A., Tsui, W.H., and Convit, A. (2012). Obesity and metabolic syndrome and functional and structural brain impairments in adolescence. Pediatrics 130, e856-864. doi: 10.1542/peds.2012-0324.
137. Yudkin, J.S., Stehouwer, C.D., Emeis, J.J., and Coppack, S.W. (1999). C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19, 972-978.
138. Zhang, T., Pan, B.S., Zhao, B., Zhang, L.M., Huang, Y.L., and Sun, F.Y. (2009). Exacerbation of Poststroke Dementia by Type 2 Diabetes Is Associated with Synergistic Increases of Beta-Secretase Activation and Beta-Amyloid Generation in Rat Brains. Neuroscience 161, 1045-1056. doi: DOI 10.1016/j.neuroscience.2009.04.032.
139. Zlokovic, B.V. (2011). Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12, 723-738. doi: 10.1038/nrn3114.